adventtr/E+ via Getty Images Trading in the month of April has come to a close. It was an eventful month. Despite little progress in resolving the conflict in the Middle East, soaring energy and commodity prices, and first quarter GDP growth estimates coming in lower than projected, the NASDAQ and S&P 500 had their best monthly performances since 2020. WTI Oil - 3 Month Price Chart (MarketWatch) T...
adventtr/E+ via Getty Images Trading in the month of April has come to a close. It was an eventful month. Despite little progress in resolving the conflict in the Middle East, soaring energy and commodity prices, and first quarter GDP growth estimates coming in lower than projected, the NASDAQ and S&P 500 had their best monthly performances since 2020. WTI Oil - 3 Month Price Chart (MarketWatch) The S&P 500 rallied 10.4% in April, and the NASDAQ was up 15.3%. Whether this performance is a testament to the market's resiliency or investor complacency, I will leave that to the reader. The market is now heading into May, which is the weakest six-month period for equity performance historically. So, what will the new month bring for investors? Three market predictions for May follow below. More Hormuz Pain: Oil has continued to spike higher due to the conflict in the Persian Gulf, and this has impacted economic growth. First quarter GDP growth projections came in at 2% Thursday, under the 2.2% consensus as previously mentioned. While this was above the .5% GDP growth in Q4, it only included one month of economic data since the Strait of Hormuz was effectively closed. The Conference Board - March 2026 That growth is likely to go lower in Q2 unless progress is made in opening up this global chokepoint. The U.S. Leading Indicator Index dipped 0.6% month-over-month in March, a steeper drop than the -0.2% consensus expected. As you can see above, the LEI has been on a steep downward trend since the Federal Reserve started to reverse nearly 15 years of ZIRP policies in March 2022. University of Michigan Gasoline prices have moved past the four-bucks-a-gallon threshold for the first time since 2022. This comes at a time when consumer sentiment is at its lowest levels since the metric first started to be polled in 1978. Jet fuel prices have soared. In response, airlines have boosted ticket prices, which were up 21% year-over-year in April. Charlie Biello - 04/24/2026 Diesel pric...
The U.S. Food and Drug Administration has permitted Revolution Medicines ( RVMD ) to make its promising investigational therapy, daraxonrasib, available to patients with pancreatic cancer outside a clinical trial setting, the company announced on Friday. The oral therapy designed to target cancer-causing mutations in the “RAS” family of genes represents a new class of cancer therapies developed by...
The U.S. Food and Drug Administration has permitted Revolution Medicines ( RVMD ) to make its promising investigational therapy, daraxonrasib, available to patients with pancreatic cancer outside a clinical trial setting, the company announced on Friday. The oral therapy designed to target cancer-causing mutations in the “RAS” family of genes represents a new class of cancer therapies developed by companies including Revolution Medicines ( RVMD ) and Erasca ( ERAS ). Daraxonrasib has already generated promising late-stage trial data indicating its potential as a late-line option for metastatic pancreatic ductal adenocarcinoma. The so-called expanded access treatment protocol allows Revolution Medicines ( RVMD ) to provide daraxonrasib to patients with metastatic PDAC in a controlled and monitored setting. Announcing promising late-stage trial data for the RAS(ON) inhibitor earlier this month, the California-based biotech said that it will submit a marketing application seeking an expedited review of daraxonrasib under the Commissioner's National Priority Voucher. More on Revolution Medicines Progress Against Pancreatic Cancer - Part 1 Revolution Medicines: 'Strong Buy' On Daraxonrasib Win And Expansions Underway Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside Revolution Medicines rival Erasca falls after early-stage trial data for cancer therapy Revolution Medicines prices $2B in concurrent stock, notes offerings
The deals come as the DoD has doubled down on diversifying its exposure to AI vendors in the wake of its controversial dispute with Anthropic over usage terms of its AI models.
The deals come as the DoD has doubled down on diversifying its exposure to AI vendors in the wake of its controversial dispute with Anthropic over usage terms of its AI models.
Tokenization holds a lot of promise but its realization is likely still some ways away, according to JPMorgan Chase's. (NYSE:JPM) global ETF product chief. Tokenization will reshape financial markets, "but we're a couple of years away from some good use...
Tokenization holds a lot of promise but its realization is likely still some ways away, according to JPMorgan Chase's. (NYSE:JPM) global ETF product chief. Tokenization will reshape financial markets, "but we're a couple of years away from some good use...
Want to get rich? Start looking for wealthy friends because having rich people in your circle can shape how you think about money and bring you closer to opportunities, according to "Rich Dad Poor Dad" author Robert Kiyosaki. Kiyosaki naturally...
Want to get rich? Start looking for wealthy friends because having rich people in your circle can shape how you think about money and bring you closer to opportunities, according to "Rich Dad Poor Dad" author Robert Kiyosaki. Kiyosaki naturally...
Trump Escalates Tariffs On EU Vehicles To 25%, Accusing Bloc Of Trade Deal Violations President Donald Trump announced Friday that the United States will raise tariffs on cars and trucks imported from the European Union to 25% starting next week , citing the EU’s failure to comply with a 2025 bilateral trade framework. "I am pleased to announce that, based on the fact the European Union is not com...
Trump Escalates Tariffs On EU Vehicles To 25%, Accusing Bloc Of Trade Deal Violations President Donald Trump announced Friday that the United States will raise tariffs on cars and trucks imported from the European Union to 25% starting next week , citing the EU’s failure to comply with a 2025 bilateral trade framework. "I am pleased to announce that, based on the fact the European Union is not complying with our fully agreed to Trade Deal, next week I will be increasing Tariffs charged to the European Union for Cars and Trucks coming into the United States. The Tariff will be increased to 25% . It is fully understood and agreed that, if they produce Cars and Trucks in U.S.A. Plants, there will be NO TARIFF.” Trump highlighted over $100 billion in ongoing U.S. auto manufacturing investments - a record, he said - and praised American workers staffing new plants set to open soon. This sent Emini S&P futures cascading lower: The move reverses a temporary reduction under the July 2025 U.S.-EU Framework Agreement on Reciprocal, Fair, and Balanced Trade. That deal, reached after Trump initially imposed broad 25% Section 232 national-security tariffs on automobiles and parts in March 2025, lowered the rate on most EU vehicles and parts to 15% (retroactive to August 1, 2025) in exchange for EU commitments. These included cutting tariffs on U.S. industrial and agricultural goods, purchasing hundreds of billions in American energy, and increasing investment in the U.S. EU implementation has lagged. The European Parliament conditionally approved enabling legislation in late March 2026 with multiple “safeguard” clauses - including a “sunrise” provision tying EU concessions to verified U.S. compliance, a suspension mechanism for new U.S. tariffs, and a sunset date in 2028. Tensions have simmered over non-tariff issues as well. In April 2026, U.S. automakers (GM, Ford, and Stellantis) warned that proposed EU safety and emissions standards could effectively block large U.S.-built p...
At least five Wall Street firms raised price targets on Roku (NASDAQ:ROKU) on May 1 following the streaming platform’s Q1 2026 beat-and-raise, with new targets ranging from $140 to $160. The synchronized wave of price target raises reflects growing conviction that Roku is the dominant gatekeeper of connected TV (CTV) modernization. For long-term investors, the ... Wall Street Lifts Roku Price Targ...
At least five Wall Street firms raised price targets on Roku (NASDAQ:ROKU) on May 1 following the streaming platform’s Q1 2026 beat-and-raise, with new targets ranging from $140 to $160. The synchronized wave of price target raises reflects growing conviction that Roku is the dominant gatekeeper of connected TV (CTV) modernization. For long-term investors, the ... Wall Street Lifts Roku Price Targets Across the Board: Is the Streaming Comeback Finally Here?
Cross-party group says closure of humanitarian unit will undermine monitoring of legal violations and arms exports MPs have expressed alarm at the closure of the Foreign Office’s international humanitarian law unit, warning it “will impair the UK’s ability to anticipate, assess and respond to serious violations of international law across multiple contexts”. News of the closure, revealed by the Gu...
Cross-party group says closure of humanitarian unit will undermine monitoring of legal violations and arms exports MPs have expressed alarm at the closure of the Foreign Office’s international humanitarian law unit, warning it “will impair the UK’s ability to anticipate, assess and respond to serious violations of international law across multiple contexts”. News of the closure, revealed by the Guardian, was raised with Keir Starmer at prime minister’s questions this week by the independent MP for Dewsbury and Batley, Iqbal Mohamed. Starmer said the work would be undertaken by another team as part of a restructuring. Continue reading...
In this week’s newsletter: Fans expecting the Vogue matriarch to pop up in Miranda Priestley’s latest outing have been disappointed – but as Hollywood history shows, guest appearances don’t always go to plan … The Devil Wears Prada 2 has a cameo list more stuffed than the fashion cupboard at the film’s fictional Runway magazine. It runs the gamut from eye-poppingly famous (Lady Gaga, Donatella Ver...
In this week’s newsletter: Fans expecting the Vogue matriarch to pop up in Miranda Priestley’s latest outing have been disappointed – but as Hollywood history shows, guest appearances don’t always go to plan … The Devil Wears Prada 2 has a cameo list more stuffed than the fashion cupboard at the film’s fictional Runway magazine. It runs the gamut from eye-poppingly famous (Lady Gaga, Donatella Versace, Naomi Campbell) to if-you-know-you-know industry famous (Tina Brown, say, or a host of supermodels familiar to anyone on the Paris front row) to “huh, how did they get there?” (Late Show bandleader Jon Batiste, or Chicken Shop Date’s Amelia Dimoldenberg, already on her second cameo of the year after a super-quick turn in an episode of Industry). Missing, though, is the one cameo everyone hoped for, the white – or should that be cerulean? – whale herself: Anna Wintour, Vogue top dog and heavy inspiration in the film for Meryl Streep’s formidable sadist-in-chief, Miranda Priestly. Wintour, though absent from the original Devil Wears Prada, always hovered over proceedings – it’s said that a number of designers steered clear of cameo appearances in the first film for fear of offending her – and Wintour herself, though present at its premiere, always studiously avoided discussing the film. But in recent months there seems to have been a sudden thawing – fond words from Wintour about the film on the New Yorker podcast, then a shock appearance alongside Streep on a Vogue cover – prompting speculation that the be-fringed one might deign to appear in the sequel. Continue reading...